Bandingkan Harga & Kinerja Sumber Energi Andalan Tbk (ITMA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sumber Energi Andalan Tbk dan Organon Pharma Indonesia Tbk.: Sumber Energi Andalan Tbk diperdagangkan di Rp1.530 (kapitalisasi pasar 1,53 T, volume 24 jam 61,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sumber Energi Andalan Tbk jauh lebih besar — sekitar 14,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ITMA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,53 T | 104,4 M |
Volume | 61,1 rb | — |
Lot | 611 | — |
Perputaran | 94,72 jt | — |
Harga Rata-rata | 1.550,26 | — |
Nilai Transaksi | 94,72 jt | — |
Harga Ekuilibrium Indikatif | 1.530 | — |
Volume Ekuilibrium Indikatif | 5 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sumber Energi Andalan Tbk
PT Sumber Energi Andalan Tbk (the Company) was established based on Notarial deed No. 6 dated September 21, 2011 of Leolin Jayayanti, S.H., notary in Jakarta. PT Sumber Energi Andalan Tbk manufactures gold jewelry such as necklaces, bracelets, rings, and pendants. The company has a factory located on a site of 18.3 Ha in the industrial estate Rungkut, Surabaya. Previously the Company's name had been changed from PT Itamaraya Gold Industry Tbk to PT Itamaraya Tbk.
Selengkapnya di halaman ITMA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
